Skip to main content

Table 2 Association between CRISP3 immunostaining and PTEN intact, hemizygous PTEN deletions and homozygous PTEN deletions

From: Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis

 

Negative/weak CRISP 3 expression n (%)

Moderate/high CRISP 3 expression n (%)

Total (n)

p-value

PTEN not deleted (n)

304(50%)

310(50%)

614

<0.0001

PTEN hemizygous deletion ( n)

53(35%)

97(65%)

150

PTEN homozygous deletion (n)

13(24%)

42(76%)

55

Total (n)

370(45%)

449(55%)

819

 
  1. Cases assessed as individual TMA cores.